Benzofuran derivatives as a novel class of inhibitors of mTOR signaling

Albert, 2010, New inhibitors of the mammalian target of rapamycin signaling pathway for cancer, Expert Opin. Investig. Drugs, 19, 919, 10.1517/13543784.2010.499121 Faivre, 2006, Current development of mTOR inhibitors as anticancer agents, Nat. Rev. Drug. Discov., 5, 671, 10.1038/nrd2062 Vignot, 2005, mTOR-targeted therapy of cancer with rapamycin derivatives, Ann. Oncol., 16, 525, 10.1093/annonc/mdi113 Kau, 2003, A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells, Cancer Cell., 4, 463, 10.1016/S1535-6108(03)00303-9 Smukste, 2003, Restoring functions of tumor suppressors with small molecules, Cancer Cell., 4, 419, 10.1016/S1535-6108(03)00307-6 J.F. Cheng, B.N. Nguyen, X. Liu, G.D. Lopaschuk, J.R. Dyck, Preparation of Heterocyclic Compounds Useful as Malonyl-CoA Decarboxylase Inhibitors, US 7696365 B2, 2005. Box, 1998, Reductive, selective deoxygenation of acylbenzo[b]furans, aromatic aldehydes and ketones with NaBH3CN-TMSCl, Tetrahedron Lett., 39, 7059, 10.1016/S0040-4039(98)01519-6 Lyubchanskaya, 1989, 2-Benzyl(isobutyl)-5-hydroxybenzofuran derivatives: synthesis and antiviral activity, Khim.-Farm. Zh., 23, 843 O'Reilly, 2006, mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt, Cancer Res., 66, 1500, 10.1158/0008-5472.CAN-05-2925 Bhagwat, 2011, Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: distinct from rapamycin, Mol. Cancer Ther., 10, 1394, 10.1158/1535-7163.MCT-10-1099 Kim, 2009, A direct approach to 5-hydroxybenzofurans via a platinum-catalyzed domino rearrangement/5-endo-dig cyclization reaction of quinols, J. Org. Chem., 74, 8492, 10.1021/jo901937u J.F. Cheng, B.N. Nguyeng, X. Liu, G.D. Lopaschuk, J. Dyck, Heterocyclic Compounds Useful as Malonyl-CoA Decarboxylase Inhibitors, US 20050026969, 2005. K. Yoshihara, D. Suzuki, Y. Susumu, Y. Hiroyoshi. M. Hisashi, S. Norio, Preparation of Guanidine Compounds as VAP-1 Inhibitors, PCT Int. Appl. WO 2012124696, 2012.